Loop Diuretic Dosage in Patients With Acute Heart Failure and Renal Failure: Conventional Versus Carbohydrate Antigen 125-guided Therapy (IMPROVE-HF)

NCT02643147 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

170

Enrollment

OTHER

Sponsor class

Conditions

Heart Failure

Interventions

DRUG: CA125 guided strategy
DRUG: CA125 guided strategy
DRUG: Conventional Strategy

Sponsor

Fundación para la Investigación del Hospital Clínico de Valencia